IL-13 induces translocation of NF-κB in cultured human bronchial smooth muscle cells

Cytokine

Volumn 46, Issue 1, 2009, Pages 96-99

  Goto, Kumiko ^a   Chiba, Yoshihiko ^a   Misawa, Miwa ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Bronchial asthma; Human bronchial smooth muscle cell; IL 13; NF B

Indexed keywords

4 (2 AMINOETHYLAMINO) 1,8 DIMETHYLIMIDAZO[1,2 A]QUINOXALINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRONCHUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SMOOTH MUSCLE FIBER;

BRONCHI; CELL NUCLEUS; HUMANS; INTERLEUKIN-13; MODELS, BIOLOGICAL; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 62749177245     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.12.021     Document Type: Article

References (25)

1. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103 (1999) 779-788
2. Zhu Z., Ma B., Homer R.J., Zheng T., and Elias J.A. Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J Biol Chem 276 (2001) 25222-25229
3. Elias J.A., Lee T.C.G., Homer R.J., Chen Q., Ma B., Blackburn M., et al. Transgenic modeling of interleukin-13 in the lung. Chest 123 (2003) 339S-345S
4. Herrick C.A., and Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 3 (2003) 405-412
5. Woodruff P.G. Gene expression in asthmatic airway smooth muscle. Proc Am Thorac Soc 5 (2008) 113-118
6. Kuperman D.A., Huang X., Koth L.L., Chang G.H., Dolganov G.M., Zhu Z., et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 8 (2002) 885-889
7. Lee J.H., Kaminski N., Dolganov G., Grunig G., Koth L., Solomon C., et al. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am J Respir Cell Mol Biol 5 (2001) 74-85
8. Lee P.J., Zhang X., Shan P., Ma B., Lee C.G., Homer R.J., et al. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J Clin Invest 16 (2006) 163-173
9. Christman J.W., Sadikot R.T., and Blackwell T.S. The role of nuclear factor kB in pulmonary diseases. Chest 117 (2000) 1482-1487
10. Zhou L.F., Zhu Y., Cui X.F., Xie W.P., Hu A.H., and Yin K.S. Arsenic trioxide, a potent inhibitor of NF-κB, abrogates allergen-induced airway hyperresponsiveness and inflammation. Respir Res 7 (2006) 146
11. Tanaka T., Grusby M.J., and Kaisho T. PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 8 (2007) 584-591
12. Hayden M.S., and Ghosh S. Signaling to NF-κB. Genes Dev 18 (2004) 2195-2224
13. Janssens S., and Tschopp J. Signals from within: the DNA-damage-induced NF-κB response. Cell Death Differ 13 (2006) 773-784
14. Ea C.K., Deng L., Xia Z.P., Pineda G., and Chen Z.J. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22 (2006) 245-257
15. Wynn T.A. IL-13 effector functions. Annu Rev Immunol 21 (2003) 425-456
16. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 202 (2004) 175-190
17. Berry M.A., Parker D., Neale N., Woodman L., Morgan A., Monk P., et al. Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol 114 (2004) 1106-1109
18. Noah T.L., Tudor G.E., Ivins S.S., Murphy P.C., Peden D.B., and Henderson F.W. Repeated measurement of nasal lavage fluid chemokines in school-age children with asthma. Ann Allergy Asthma Immunol 96 (2006) 304-310
19. Prieto J., Lensmar C., Roquet A., van der Ploeg I., Gigliotti D., Eklund A., et al. Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med 94 (2000) 806-814
20. Batra V., Musani A.I., Hastie A.T., Khurana S., Carpenter K.A., Zangrilli J.G., et al. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 34 (2004) 437-444
21. Grunstein M.M., Hakonarson H., Leiter J., Chen M., Whelan R., Grunstein J.S., et al. IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 282 (2002) L520-L528
22. Laporte J.C., Moore P.E., Baraldo S., Jouvin M.H., Church T.L., Schwartzman I.N., et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 164 (2001) 141-148
23. Andrews A.L., Holloway J.W., Puddicombe S.M., Holgate S.T., and Davies D.E. Kinetic analysis of the interleukin-13 receptor complex. J Biol Chem 277 (2002) 46073-46078
24. Palmer-Crocker R.L., Hughes C.C., and Pober J.S. IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J Clin Invest 98 (1996) 604-609
25. Chapoval S.P., Al-Garawi A., Lora J.M., Strickland I., Ma B., Lee P.J., et al. Inhibition of NF-κB activation reduces the tissue effects of transgenic IL-13. J Immunol 179 (2007) 7030-7041